Medtronic's implantable drug pump approved in US:
This article was originally published in Clinica
Executive Summary
Medtronic has received US FDA approval for its IsoMed constant-flow infusion system, an implantable drug pump for the treatment of colorectal liver cancer. The pump is surgically placed under the skin of the abdomen and delivers cancer-fighting medication directly to the liver, assisted by a catheter that runs from the pump to the hepatic artery. The system can also deliver morphine sulphate directly into spinal fluid as a treatment for chronic back pain, said the Minneapolis, Minnesota-based company.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.